The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure - A Multicenter, Randomized, Double-blind, Placebo Controlled, Parallel Group Clinical Study
Phase of Trial: Phase II
Latest Information Update: 05 Sep 2017
At a glance
- Drugs Istaroxime (Primary)
- Indications Decompensated heart failure
- Focus Therapeutic Use
- Sponsors Lee Pharmaceuticals
- 31 Aug 2017 Planned End Date changed from 1 Oct 2016 to 1 Oct 2018.
- 31 Aug 2017 Planned primary completion date changed from 1 Aug 2016 to 1 Aug 2018.
- 31 Aug 2017 Status changed from not yet recruiting to recruiting.